Managing Early-Stage Resectable Non-Small Cell Lung Cancer: Through the Eyes of the Patient and t...

preview_player
Показать описание
How prepared are you to talk about available perioperative immunotherapies for early-stage resectable non-small cell lung cancer (NSCLC) with your patients?


  1. Medscape
Рекомендации по теме
Managing Early-Stage Resectable 0:35:53

Managing Early-Stage Resectable Non-Small Cell Lung Cancer: Through the Eyes of the Patient and t...

Early-Stage Resectable Non-Small 0:36:16

Early-Stage Resectable Non-Small Cell Lung Cancer: Navigating a Changing Treatment Landscape

Early-Stage Resectable Non-Small 0:35:18

Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives

Current Management of 0:58:15

Current Management of Stage IIIA Non-Small Cell Lung Cancer: A Changing Paradigm (November 10, 2022)

Immunotherapy for early-stage, 0:32:52

Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines

Multimodal Management of 0:41:23

Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative Settings

Resectable Early Stage 0:06:55

Resectable Early Stage Non Small Cell Lung Cancer

Immunotherapy for Early-Stage 0:29:49

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

#EGFR & #ALK 1:08:18

#EGFR & #ALK updates led by Drs. Antonoff & Reckamp from #STS2025 - bit.ly/Targeted-LAY

Management of early 0:07:47

Management of early stage and resectable LA bronchogenic carcinoma

Realizing the Promise 0:43:46

Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC

Advances in Immunotherapy 0:45:21

Advances in Immunotherapy & Resectable Non-Small Cell Lung Cancer

The role of 0:17:29

The role of surgery in early-stage NSCLC management | Jessica Donington

TOPS Levine Cancer 0:07:30

TOPS Levine Cancer Institute: Guideline-Recommended Biomarker Testing in Early-Stage NSCLC

Has Immunotherapy Brought 1:08:00

Has Immunotherapy Brought Us to an Inflection Point in the Management of Stage I-III NSCLC?

Advanced NSCLC: Refining 0:44:56

Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape

ASCO 2022 highlights 0:51:22

ASCO 2022 highlights on early stage lung cancer management

Immunotherapies in Lung 0:26:13

Immunotherapies in Lung Cancer | 2022 Evolution Conference

AEGEAN Study - 0:19:14

AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer

Can the Addition 1:05:29

Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Improve Outcomes?

Immunotherapy as combination 0:03:44

Immunotherapy as combination and neoadjuvant therapies in NSCLC

Clinical and translational 0:04:19

Clinical and translational results from the NEOSTAR study: treating early-stage lung cancer with...

Grand Rounds | 1:01:41

Grand Rounds | Dr. Juergens | The changing paradigm for management of resectable lung cancer

Addressing Unmet Needs 0:11:22

Addressing Unmet Needs for Patients With Resectable NSCLC and the Benefits of an MDT Approach